These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 34668731)

  • 1.
    Li X; Le W; Lou X; Wang B; Genco CA; Rice PA; Su X
    Microbiol Spectr; 2021 Oct; 9(2):e0018121. PubMed ID: 34668731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Synergy Testing of Gentamicin, an Old Drug Suggested as Future Treatment Option for Gonorrhoea, in Combination With Six Other Antimicrobials Against Multidrug-Resistant Neisseria gonorrhoeae Strains.
    Singh V; Bala M; Bhargava A; Kakran M; Bhatnagar R
    Sex Transm Dis; 2018 Feb; 45(2):127-131. PubMed ID: 28876284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro assessment of gentamicin and azithromycin-based combination therapy against Neisseria gonorrhoeae isolates in India.
    Sood S; Agarwal SK; Singh R; Gupta S; Sharma VK
    J Med Microbiol; 2019 Apr; 68(4):555-559. PubMed ID: 30869583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of in vitro synergy for dual antimicrobial therapy against resistant Neisseria gonorrhoeae using Etest and agar dilution.
    Wind CM; de Vries HJ; van Dam AP
    Int J Antimicrob Agents; 2015 Mar; 45(3):305-8. PubMed ID: 25532741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy for gonorrhoea: in vitro synergy testing.
    Pereira R; Cole MJ; Ison CA
    J Antimicrob Chemother; 2013 Mar; 68(3):640-3. PubMed ID: 23152483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro efficacy of 21 dual antimicrobial combinations comprising novel and currently recommended combinations for treatment of drug resistant gonorrhoea in future era.
    Singh V; Bala M; Bhargava A; Kakran M; Bhatnagar R
    PLoS One; 2018; 13(3):e0193678. PubMed ID: 29509792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea?
    Unemo M; Golparian D; Limnios A; Whiley D; Ohnishi M; Lahra MM; Tapsall JW
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3603-9. PubMed ID: 22547617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of antimicrobial resistance selection in Neisseria gonorrhoeae.
    Allen GP; Deao KM; Hill SA; Schipelliti SM; Tran T
    Int J Antimicrob Agents; 2021 Oct; 58(4):106417. PubMed ID: 34391903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016.
    Katz AR; Komeya AY; Kirkcaldy RD; Whelen AC; Soge OO; Papp JR; Kersh EN; Wasserman GM; O'Connor NP; O'Brien PS; Sato DT; Maningas EV; Kunimoto GY; Tomas JE
    Clin Infect Dis; 2017 Sep; 65(6):918-923. PubMed ID: 28549097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae.
    Barbee LA; Soge OO; Holmes KK; Golden MR
    J Antimicrob Chemother; 2014 Jun; 69(6):1572-8. PubMed ID: 24468865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
    Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M;
    BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of antimicrobial combinations against clinical isolates of Neisseria gonorrhoeae.
    Furuya R; Koga Y; Irie S; Ikeda F; Kanayama A; Kobayashi I; Tanaka M
    J Infect Chemother; 2013 Dec; 19(6):1218-20. PubMed ID: 23564350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.
    Jiang FX; Lan Q; Le WJ; Su XH
    BMC Infect Dis; 2017 May; 17(1):366. PubMed ID: 28545411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential.
    Lagacé-Wiens PRS; Adam HJ; Laing NM; Baxter MR; Martin I; Mulvey MR; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2017 Aug; 72(8):2273-2277. PubMed ID: 28505331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
    Day MJ; Jacobsson S; Spiteri G; Kulishev C; Sajedi N; Woodford N; Blumel B; van der Werf MJ; Amato-Gauci AJ; Unemo M; Cole MJ;
    BMC Infect Dis; 2022 Jun; 22(1):524. PubMed ID: 35672671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of multidrug-resistant
    Yuan Q; Li Y; Xiu L; Zhang C; Fu Y; Jiang C; Tang L; Peng J
    Emerg Microbes Infect; 2019; 8(1):1546-1549. PubMed ID: 31661379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High percentages of resistance to tetracycline and penicillin and reduced susceptibility to azithromycin characterize the majority of strain types of Neisseria gonorrhoeae isolates in Cuba, 1995-1998.
    Sosa J; Ramirez-Arcos S; Ruben M; Li H; Llanes R; Llop A; Dillon JA
    Sex Transm Dis; 2003 May; 30(5):443-8. PubMed ID: 12916137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro potency and combination testing of antimicrobial agents against Neisseria gonorrhoeae.
    Bharat A; Martin I; Zhanel GG; Mulvey MR
    J Infect Chemother; 2016 Mar; 22(3):194-7. PubMed ID: 26603424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.